Robertson Jenny's Form 4 filing
Lexeo Therapeutics, Inc. (LXEO) · filed Feb 21, 2025
- Accession no.
- 0001415889-25-005108
- Filed
- Feb 21, 2025
- Trade date
- Feb 19, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $9.27K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robertson JennyCIK 0001995009 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | Common Stock | SSaleDisposed | −2,101 | $4.41 | −$9,265.41 | 57,899 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.